Changes Ahead: CMS Tightens Formulary Transparency for 2025 Silver and Gold Marketplace Plans
Beginning January 1, 2025, the Centers for Medicare & Medicaid Services (CMS) will require insurers on the ACA marketplaces to show formulary tiers directly within plan comparison tools for silver and gold-level plans. This isn’t just a cosmetic tweak. It means consumers will finally see how a drug is covered, not just whether it’s listed. The rule applies across all Federally-Facilitated Marketplaces (FFMs) and to state-based marketplaces that use the federal platform.
What Happens Now vs. What’s Coming
Right now, checking drug coverage on HealthCare.gov often sends you down a PDF rabbit hole with hundreds of entries and little clarity on tier placement. And tier placement is what drives out-of-pocket cost. Under the 2025 change, that data must be structured and machine-readable under CMS’s “Prescription Drug Data Collection” standards. Less hunting, more clarity.
| Feature | Prior (2024) | New (2025) |
|---|---|---|
| Display of formulary drug tiers | Only shown in PDF or separate plan document | Must be visible on the plan preview page |
| Data format | Unstructured lists | Standardized JSON format for public download |
| Who must comply | Optional for issuers | Mandatory for all silver and gold marketplace plans |
How This Plays Out for Common Drugs
Take rosuvastatin, the generic for Crestor. Among 2024 silver-tier plans, it usually lands on Tier 1 or Tier 2, with copays between $0 and $20 per month based on CMS Formulary Reference Files. Come 2025, that tier and price information will be front and center before enrollment rather than buried in documentation. That kind of visibility spares a lot of people with cholesterol management needs from midyear cost surprises.
Insulin glargine, sold as Lantus by Sanofi, is another example. It’s often Tier 3 on gold plans, meaning coinsurance between 25% and 40%. When tier data becomes public and standardized, anyone dependent on insulin can more easily spot which plans treat their medication more favorably. Look, that’s overdue transparency.
Why It All Matters
Roughly four in ten marketplace enrollees fill at least one prescription each month. Tier display at the comparison stage should make it easier to weigh real price differences and avoid unwelcome pharmacy surprises. For benefits managers and pharmacists, this shift supports more accurate guidance during open enrollment, finally aligning plan marketing with real-world cost implications.
Disclaimer: This content is for general informational purposes and does not constitute medical, legal, or insurance advice. Always review plan documents and consult licensed professionals before making coverage decisions.